CN113613642B - 取代的氨基-硫醇和氨基-二硫化物化合物及其用途 - Google Patents
取代的氨基-硫醇和氨基-二硫化物化合物及其用途 Download PDFInfo
- Publication number
- CN113613642B CN113613642B CN202080024298.3A CN202080024298A CN113613642B CN 113613642 B CN113613642 B CN 113613642B CN 202080024298 A CN202080024298 A CN 202080024298A CN 113613642 B CN113613642 B CN 113613642B
- Authority
- CN
- China
- Prior art keywords
- compound
- cystamine
- cysteamine
- deuterated
- levels
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962823892P | 2019-03-26 | 2019-03-26 | |
| US62/823892 | 2019-03-26 | ||
| PCT/US2020/025067 WO2020198529A1 (en) | 2019-03-26 | 2020-03-26 | Substituted amino-thiol and amino-disulfide compounds, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113613642A CN113613642A (zh) | 2021-11-05 |
| CN113613642B true CN113613642B (zh) | 2024-08-06 |
Family
ID=72610131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202080024298.3A Active CN113613642B (zh) | 2019-03-26 | 2020-03-26 | 取代的氨基-硫醇和氨基-二硫化物化合物及其用途 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12391643B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3946298A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7538541B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113613642B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020198529A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021022012A1 (en) * | 2019-07-30 | 2021-02-04 | The Regents Of The University Of California | Methods and composition for treating respiratory obstructive diseases |
| JP2022188184A (ja) * | 2022-10-04 | 2022-12-20 | Sc有機化学株式会社 | 硫黄化合物含有組成物及び樹脂組成物 |
| CN115745857B (zh) * | 2022-10-28 | 2025-10-17 | 中国医学科学院放射医学研究所 | 一类口服给药的活性氧响应的硫酯类化合物、合成方法及用途 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103442704A (zh) * | 2011-02-23 | 2013-12-11 | 拉瓦勒大学 | 用于治疗帕金森病的胱胺类似物 |
| CN107106875A (zh) * | 2014-11-05 | 2017-08-29 | 霍里森罕见药有限公司 | 使用半胱胺组合物治疗亨廷顿氏病的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5254730A (en) * | 1992-01-14 | 1993-10-19 | Kilgore James L | Production of amino acids and amino acid derivatives bearing isotopic hydrogen labels |
| WO2007089670A2 (en) | 2006-01-27 | 2007-08-09 | The Regents Of The University Of California | Enterically coated cysteamine, cystamine and derivatives thereof |
| US7750168B2 (en) * | 2006-02-10 | 2010-07-06 | Sigma-Aldrich Co. | Stabilized deuteroborane-tetrahydrofuran complex |
| WO2009070781A1 (en) | 2007-11-30 | 2009-06-04 | The Regents Of The University Of California | Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products |
| US8530479B2 (en) | 2009-08-10 | 2013-09-10 | Daljit Singh Dhanoa | Deuterium-enriched alkyl sulfonamides |
| MX392606B (es) * | 2016-03-17 | 2025-03-24 | Thiogenesis Therapeutics Inc | Composiciones para la liberacion controlada de cisteamina y el tratamiento sistemico de trastornos sensibles a la cisteamina. |
| WO2021022012A1 (en) | 2019-07-30 | 2021-02-04 | The Regents Of The University Of California | Methods and composition for treating respiratory obstructive diseases |
-
2020
- 2020-03-26 WO PCT/US2020/025067 patent/WO2020198529A1/en not_active Ceased
- 2020-03-26 EP EP20778142.8A patent/EP3946298A4/en active Pending
- 2020-03-26 CN CN202080024298.3A patent/CN113613642B/zh active Active
- 2020-03-26 US US17/429,885 patent/US12391643B2/en active Active
- 2020-03-26 JP JP2021555221A patent/JP7538541B2/ja active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103442704A (zh) * | 2011-02-23 | 2013-12-11 | 拉瓦勒大学 | 用于治疗帕金森病的胱胺类似物 |
| CN107106875A (zh) * | 2014-11-05 | 2017-08-29 | 霍里森罕见药有限公司 | 使用半胱胺组合物治疗亨廷顿氏病的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3946298A4 (en) | 2023-01-25 |
| EP3946298A1 (en) | 2022-02-09 |
| US12391643B2 (en) | 2025-08-19 |
| JP2022525148A (ja) | 2022-05-11 |
| CN113613642A (zh) | 2021-11-05 |
| JP7538541B2 (ja) | 2024-08-22 |
| WO2020198529A1 (en) | 2020-10-01 |
| US20220135524A1 (en) | 2022-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6177832B2 (ja) | アルギナーゼ阻害剤および使用方法 | |
| US9993449B2 (en) | (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds as GABA aminotransferase inactivators for the treatment of epilepsy, addiction and hepatocellular carcinoma | |
| CN115490681B (zh) | 三嗪衍生物 | |
| TW200843778A (en) | Pterin analogs | |
| JP7538541B2 (ja) | 置換されたアミノチオール及びアミノジスルフィド化合物、及びそれらの使用 | |
| EP3316877B1 (en) | Ado-resistant cysteamine analogs and uses thereof | |
| US20190040029A1 (en) | A type of aryl benzofuran amidated derivative and medical use thereof | |
| US12221428B2 (en) | Use of deuterated empathogens as therapeutic agents | |
| WO1999057120A9 (en) | Novel serotonin-like 9-substituted hypoxanthine and methods of use | |
| EP1143951A2 (en) | Antimalarial agents | |
| JP2004517105A (ja) | ビグアニンとキャリア、例えばメトホルミンとアルギニンの薬効的関連 | |
| CA3053344A1 (en) | Treatment of diabetes and associated metabolic conditions with epigenetic modulators | |
| CN109096219B (zh) | 一种新型抗pd-l1化合物、其应用及含其的组合物 | |
| ES2963560T3 (es) | Compuesto piramidin-5-carboxamida | |
| US11203596B2 (en) | Analogs of 3-amino-4-(propan-2-ylidene)cyclopentane-1-carboxylic acid and uses thereof for treating diseases and disorders associated with ornithine aminotransferase activity | |
| US20250066292A1 (en) | Cysteamine and/or cystamine prodrugs | |
| SG188472A1 (en) | Prodrugs of guanfacine | |
| KR20160146689A (ko) | 파킨슨병을 치료하기 위한 도파민 효능제 및 l-dopa 유도체를 포함하는 조성물 | |
| CN111163765A (zh) | 用于抑制胆碱向三甲胺(tma)的转化的方法 | |
| CN110577480A (zh) | 一种抗β淀粉样蛋白活性的化合物的制备方法和应用 | |
| US9505743B2 (en) | Matrix metalloproteinase inhibitors and methods for the treatment of pain and other diseases | |
| JP3969831B2 (ja) | ハイドロキシプロリン誘導体 | |
| US20240245647A1 (en) | Isomerohydrolase inhibitor for treatment of atrophic form of age-related macular degeneration and stargardt disease | |
| US20260008750A1 (en) | Compounds, compositions, and methods for reducing production of trimethylamine | |
| JP2011190257A (ja) | 組織線維化疾患の予防または治療剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |